Toshiaki Iwase

11PUBLICATIONS
44CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 01, 2026
Pervasive enhanced transcription in inflammatory breast cancer tumors and PBMCs impacts RNA splicing and intronic RNAs in plasma.

|Apr 17, 2024
Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy.

Toshiaki Iwase, Evan N Cohen, Hui Gao

|Jul 03, 2023
TGIRT-seq of Inflammatory Breast Cancer Tumor and Blood Samples Reveals Widespread Enhanced Transcription Impacting RNA Splicing and Intronic RNAs in Plasma.

Dennis Wylie, Xiaoping Wang, Jun Yao

|Mar 29, 2023
Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines.

Xuemei Xie, Jangsoon Lee, Jon A Fuson

|Dec 16, 2022
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer.

Xiaoping Wang, Takashi Semba, Ganiraju C Manyam

|Oct 13, 2021
A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer.

Toshiaki Iwase, Kim R M Blenman, Xiaotong Li

Pageof 2

Frequent Collaborators

10 joint publications

Naoto T Ueno

4 joint publications

Debu Tripathy

4 joint publications

Xiaoping Wang

2 joint publications

Takashi Semba